Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-006934
Filing Date
2021-06-21
Accepted
2021-06-21 17:37:13
Documents
2
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 17365
2 EX-24 ex24tessari.htm EX-24.EX-24 10022
  Complete submission text file 0001179110-21-006934.txt   28872
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Tessari Eben (Reporting) CIK: 0001867899 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38492 | Film No.: 211032169